Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trisomy 2 in proliferative fasciitis.

A Dembinski1, J A Bridge, J R Neff

  • 1Department of Pathology, University of Nebraska Medical Center, Omaha 68198-5440.

Cancer Genetics and Cytogenetics
|May 1, 1992
PubMed
Summary

Trisomy 2 was identified as the only genetic change in a proliferative fasciitis case. This marks the first cytogenetic analysis reported for this rare condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.

Human pathology·1992
Same author

Translocation (X;1)(p11.2;q21). A subtype of renal adenocarcinomas.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and molecular studies of a familial renal cell carcinoma.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.

Cancer genetics and cytogenetics·1992
Same author

Application of fluorescence in situ hybridization in hematological disorders.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.

Cancer genetics and cytogenetics·1992

Area of Science:

  • Cytogenetics
  • Pathology
  • Oncology

Background:

  • Proliferative fasciitis is a rare, benign soft tissue proliferation that can mimic malignancy.
  • Accurate diagnosis is crucial to avoid unnecessary aggressive treatment.

Observation:

  • A case of proliferative fasciitis presented with a unique clonal karyotypic abnormality.
  • The sole abnormality detected was trisomy 2.

Findings:

  • Trisomy 2 was confirmed as the exclusive clonal cytogenetic alteration in the proliferative fasciitis examined.
  • This represents the inaugural cytogenetic report detailing the chromosomal makeup of proliferative fasciitis.

Implications:

  • Understanding the genetic landscape of proliferative fasciitis can aid in differential diagnosis.
  • Further cytogenetic studies may reveal specific genetic drivers or subtypes of this condition.

Related Experiment Videos